The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework
This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
The purchase of implant manufacturer, Mentor Corporation, by Johnson and Johnson will level the playing field as Mentor seeks to take market share from Allergan in both the breast implant business as well as facial fillers and competitors to Botox.
Over the past few years, noninvasive cosmetic procedures have skyrocketed. Soft tissue injectable fillers are among those procedures that are rapidly growing. Up until now, hyaluronic acid (HA) fillers have been the mainstay. With the emergence of Envolence, we have a new twist on...
The title of this invitation is misleading. The study is regarding a speific item, red yeast rice purified extract, in the very spcific situation of preventing recurrent myocardial infarction after cadiac bypass surgery. While this is interesting, it is not yet a studied and proven therapy. It may be...
Only FDA approved fillers administered by experienced, licensed physicians should be injected into patients. Also, the small volumes that are used today should not pose systemic problems that were seen in this article.
1. Lilly should be pleased with approval of Strattera in children and adolescents 2. Strattera is the superior agent for ADHD 3. approval should boost Liily sales
Juvista appears to be effective in improving scar quality according to recently released Phase II results. Renovo reported no clinical improvement in breast augmentation scars treated with a single injection of the drug.
It is not unexpected that Medicis is expanding into the "Botox" business since its rival company, Allergan, has a monopoly on the market. Allergan also has Juviderm, which competes directly with Restylane, the hit product by Medicis. This will place Medicis back into the competitive market...